| Exhibit Number | Exhibit Description |
|---|
| 3.1(1) | Amended and Restated Certificate of Incorporation, as amended May 29, 2024 |
| 3.2(2) | Amended and Restated Bylaws |
| 4.1(3) | Form of Securities Purchase and Registration Rights Agreement, dated April 22, 2025, by and among the Company and the Investors |
| 4.1(4) | Form of Securities Purchase and Registration Rights Agreement, dated June 30, 2025, by and among the Company and the Investors |
| 31.1* | Certification of Principal Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|---|
| 31.2* | Certification of Principal Financial Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|---|
| 101.INS+ | Inline XBRL Instance Document |
| 101.SCH+ | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL+ | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF+ | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB+ | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE+ | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101) |
| * | Filed herewith. |
| ** | Furnished herewith. |
| + | The financial information contained in these XBRL documents is unaudited and is furnished, not filed with the Securities and Exchange Commission. |
| (2) | Previously filed as Exhibit 3.1 to the Current Report on Form 8-K filed by us on May 1, 2023. |
| (3) | Previously filed as Exhibit 4.1 to the Current Report on Form 8-K filed by us on April 23, 2025. |
| (4) | Previously filed as Exhibit 4.1 to the Current Report on Form 8-K filed by us on July 2, 2025. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| BIOCARDIA, INC. (Registrant) | |
| Date: August 11, 2025 | By: | /s/ Peter Altman |
|---|
| Peter Altman |
| President and Chief Executive Officer |
| (Principal Executive Officer) |
| Date: August 11, 2025 | By: | /s/ David McClung |
|---|
| David McClung |
| Chief Financial Officer |
| (Principal Financial and Accounting Officer) |
